Brca1 Mutation Carrier Completed Phase 2 Trials for Rucaparib (DB12332)

Back to Brca1 Mutation Carrier

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerTreatment